Dr. Tibor P. Palfai's lab at Boston University's Psychology Department focuses on understanding how alcohol affects sexual decision-making, particularly among men who have sex with men (MSM). The lab conducts research on the mechanisms behind risky sexual behaviors when individuals are intoxicated and seeks to promote safer behaviors through innovative brief interventions. Their work integrates cognitive and motivational approaches to help reduce the risk of HIV transmission by enhancing condom use and lowering alcohol consumption.

Dr. Todd J. Farchione's lab at Boston University focuses on improving digital mental health interventions through the use of machine learning. By developing precision treatment rules, the lab aims to personalize treatment options for patients and enhance user engagement, ultimately leading to better clinical outcomes. The research is conducted in collaboration with primary care physicians, utilizing a large-scale clinical trial to test various digital intervention strategies.

Dr. Michael W. Otto's lab at Boston University focuses on understanding how anxiety disorders respond to exposure-based therapy—a common treatment method. The lab is investigating the potential of measuring carbon dioxide reactivity as a biomarker to predict whether patients will benefit from this therapy. This research aims to improve treatment selection for patients suffering from anxiety-related disorders and enhance the overall effectiveness of mental health interventions.

Dr. Anthony Joseph Rosellini's lab at Boston University focuses on understanding social anxiety disorder and improving treatment outcomes through neuroimaging techniques. The research aims to identify neural markers that can predict how well patients respond to therapies like cognitive behavioral therapy (CBT) and medication. By collecting and analyzing data from brain scans and behavioral assessments, the lab seeks to provide insights that could lead to more personalized treatment strategies for individuals suffering from social anxiety.